In March 2025, the company introduced new options for any immediate-to-consumer giving of its Wegovy weight loss drug. The company proven a completely new pharmacy, referred to as NovoCare, which might charge consumers $499 a month for access to the drug, less than fifty percent the price of the drug via other pharmaceutical distribution networks.[